Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Ruggieri

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Therapeutics and Clinical Risk Management|March 14, 2013
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimodClaudio Gasperini, Serena Ruggieri, Chiara Rosa Mancinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world contextLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Neurology India|December 21, 2019
Tumefactive Demyelinating Lesions and PregnancyDomenico Plantone, Carlo Piantadosi, Serena Ruggieri, et al.
Frontiers in Neurology|April 24, 2023
Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case reportElena Barbuti, Riccardo Nistri, Antonio Ianniello, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2023
Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
JAMA Neurology|April 4, 2018
Listeria monocytogenes-Induced Rhombencephalitis in a Patient With Multiple Sclerosis Treated With Dimethyl FumarateSerena Ruggieri, Alessandra Logoteta, Gabriella Martini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2020
'Posture second' strategy predicts disability progression in multiple sclerosisLetizia Castelli, Maria Esmeralda Quartuccio, Serena Ruggieri, et al.
Journal of Neurology|January 5, 2022
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
International Journal of Molecular Sciences|June 12, 2019
Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple SclerosisMarta Corsetti, Gabriella Ruocco, Serena Ruggieri, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Therapeutics and Clinical Risk Management|March 14, 2013
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimodClaudio Gasperini, Serena Ruggieri, Chiara Rosa Mancinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world contextLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Neurology India|December 21, 2019
Tumefactive Demyelinating Lesions and PregnancyDomenico Plantone, Carlo Piantadosi, Serena Ruggieri, et al.
Frontiers in Neurology|April 24, 2023
Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case reportElena Barbuti, Riccardo Nistri, Antonio Ianniello, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2023
Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
JAMA Neurology|April 4, 2018
Listeria monocytogenes-Induced Rhombencephalitis in a Patient With Multiple Sclerosis Treated With Dimethyl FumarateSerena Ruggieri, Alessandra Logoteta, Gabriella Martini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2020
'Posture second' strategy predicts disability progression in multiple sclerosisLetizia Castelli, Maria Esmeralda Quartuccio, Serena Ruggieri, et al.
Journal of Neurology|January 5, 2022
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
International Journal of Molecular Sciences|June 12, 2019
Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple SclerosisMarta Corsetti, Gabriella Ruocco, Serena Ruggieri, et al.
Pageof 11